A Diabetes Study to Treat A Population Previously Not at Target
NCT ID: NCT00747149
Last Updated: 2011-08-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
598 participants
INTERVENTIONAL
2008-05-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rosuvastatin 1
titrated
Rosuvastatin
Oral
Rosuvastatin 2
Non-titrated
Rosuvastatin
Oral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rosuvastatin
Oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously treated with a commonly accepted start dose of a statin for the last 4 weeks prior to study entry
* Fasting LDL-C concentration of \> 2.0 mmol/L (and ≤ 5.0 mmol/L) (in the past 3 months)
* History of serum TG level of ≤ 4.6 mmol/l (in the past 3 months)
Exclusion Criteria
* Rosuvastatin (current use)
* Fibrates, niacin or resins that was not discontinued a minimum of 2 months prior to enrolment.
* Type 1 diabetes; glycated haemoglobin (HbA1c) \> 9.0%
* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level ≥ 1.5 × upper limit of normal (ULN) (in the past 2 months)
* Resting diastolic or systolic blood pressure of \> 95 mmHg or \> 180 mmHg, respectively (in the past 2 months)
* Unexplained serum creatine kinase (CK) level \> 3 × ULN (in the past 2 months).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davide Meani
Role: STUDY_DIRECTOR
AstraZeneca
David Lau, MD
Role: PRINCIPAL_INVESTIGATOR
Private Practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Red Deer, Alberta, Canada
Research Site
Spruce Grove, Alberta, Canada
Research Site
St. Albert, Alberta, Canada
Research Site
Chilliwack, British Columbia, Canada
Research Site
Coquitlam, British Columbia, Canada
Research Site
Delta, British Columbia, Canada
Research Site
Kelowna, British Columbia, Canada
Research Site
Maple Ridge, British Columbia, Canada
Research Site
Penticton, British Columbia, Canada
Research Site
Victoria, British Columbia, Canada
Research Site
Portage la Prairie, Manitoba, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Bathurst, New Brunswick, Canada
Research Site
Woodstock, New Brunswick, Canada
Research Site
Carbonear, Newfoundland and Labrador, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Kentville, Nova Scotia, Canada
Research Site
Pubnico, Nova Scotia, Canada
Research Site
Sydney Mines, Nova Scotia, Canada
Research Site
Truro, Nova Scotia, Canada
Research Site
Aylmer, Ontario, Canada
Research Site
Bolton, Ontario, Canada
Research Site
Chatham, Ontario, Canada
Research Site
Fort Erie, Ontario, Canada
Research Site
Georgetown, Ontario, Canada
Research Site
Greater Sudbury, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Kingston, Ontario, Canada
Research Site
Kitchener, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
Morrisburg, Ontario, Canada
Research Site
Nepean, Ontario, Canada
Research Site
Newmarket, Ontario, Canada
Research Site
North York, Ontario, Canada
Research Site
Oshawa, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Saint Catherines, Ontario, Canada
Research Site
Scaborough, Ontario, Canada
Research Site
Scarborough Village, Ontario, Canada
Research Site
Smith Falls, Ontario, Canada
Research Site
St. Catharines, Ontario, Canada
Research Site
Thornhill, Ontario, Canada
Research Site
Thorold, Ontario, Canada
Research Site
Thunder Bay, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Welland, Ontario, Canada
Research Site
Willowdale, Ontario, Canada
Research Site
Windsor, Ontario, Canada
Research Site
Woodstock, Ontario, Canada
Research Site
Charlottetown, Prince Edward Island, Canada
Research Site
Kensington, Prince Edward Island, Canada
Research Site
Montague, Prince Edward Island, Canada
Research Site
Anjou, Quebec, Canada
Research Site
Dolbeau-Mistassini, Quebec, Canada
Research Site
Drummondville, Quebec, Canada
Research Site
Forestville, Quebec, Canada
Research Site
Gatineau, Quebec, Canada
Research Site
Joliette, Quebec, Canada
Research Site
L'Ile Perrot, Quebec, Canada
Research Site
La Sarre, Quebec, Canada
Research Site
Laval, Quebec, Canada
Research Site
Longueuil, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Roberval, Quebec, Canada
Research Site
Roxton Pond, Quebec, Canada
Research Site
Saint-bruno-lac-saint-jean, Quebec, Canada
Research Site
Saint-Charles-Borromée, Quebec, Canada
Research Site
Saint-Léonard, Quebec, Canada
Research Site
Saint-Marc-des-Carrieres, Quebec, Canada
Research Site
Saint-Pie, Quebec, Canada
Research Site
Sainte Gedeon-de-beauce, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Research Site
Thetford-Mines, Quebec, Canada
Research Site
Trois-Rivières, Quebec, Canada
Research Site
Moose Jaw, Saskatchewan, Canada
Research Site
Porcupine Plain, Saskatchewan, Canada
Research Site
Saskatoon, Saskatchewan, Canada
Research Site
Yorkton, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D3560L00072
Identifier Type: -
Identifier Source: org_study_id